The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Michael P. Cancro(University of Pennsylvania), Munther A. Khamashta(The King's College)
Cited by 275
Related Papers
The “Primary” Antiphospholipid Syndrome
|Medicine|1989|963
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
|The Lancet Haematology|2016|404
Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti‐β<sub>2</sub>‐Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β<sub>2</sub>‐Glycoprotein I and Induce Endothelial Activation
|Arthritis & Rheumatism|1997|290
The BLyS Family: Toward a Molecular Understanding of B Cell Homeostasis
|Cell Biochemistry and Biophysics|2008|102